相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Determinants of maximal dose titration of sacubitril/valsartan in clinical practice
Pieter Martens et al.
ACTA CARDIOLOGICA (2021)
Sacubitril-Valsartan in a routine community population: attention to volume status critical to achieving target dose
Rebabonye B. Pharithi et al.
ESC HEART FAILURE (2020)
Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting
Charlotte Nordberg Backelin et al.
ESC HEART FAILURE (2020)
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF
Michael R. Zile et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
No Aldosterone Breakthrough With the Neprilysin Inhibitor Sacubitril
Giuseppe Vergaro et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
1410Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study
D Pascual-Figal et al.
EUROPEAN HEART JOURNAL (2019)
Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial
Rayan Jo Rachwan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Effects of sacubitril/valsartan on functional status and exercise capacity in real-world patients
Chirik Wah Lau et al.
ACTA CARDIOLOGICA (2019)
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction
Giuseppe Vergaro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study
Michele Senni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial
Muthiah Vaduganathan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF
Michael Bohm et al.
EUROPEAN HEART JOURNAL (2017)
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial
Orly Vardeny et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Societa Italiana di Biochimica Clinica (SIBIOC)
Antonio Fortunato et al.
CLINICA CHIMICA ACTA (2015)
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism
Giuseppe Vergaro et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2015)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease
Roberta Poletti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Prognostic Value of Plasma Renin Activity in Heart Failure
Giuseppe Vergaro et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin
Alberto Morganti
JOURNAL OF HYPERTENSION (2010)
分享论文
